AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Private investment firm Gryphon Investors said on Thursday it had agreed to sell Shermco, its portfolio company, to Blackstone in a deal valued at about $1.6 billion. Reuters, the news and media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results